COSCIENS Biopharma Inc. (CSCIF) KPIs and segments
Close on Oct 19, 2026Market cap $24.10MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive COSCIENS Biopharma's business
COSCIENS Biopharma's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Active ingredient($M) | 1.76 | 1.48 | 2.42 | 1.39 | 2.39 | 1.71 | 2.33 | 2.06 | 1.21 | 1.95 | 1.39 | ||
Biopharmaceutical($M) | 0.93 | 0.16 | 0.00 | ||||||||||
Pharmaceutical($M) | 0.01 | 0.33 | 0.11 | 0.93 | 0.16 | 0.00 | |||||||
Earlier reporting (last reported 2023)4 | |||||||||||||
Biopharmaceutical($M) | 0.86 | 0.09 | -0.00 | ||||||||||
Active ingredient($M) | 0.66 | 0.62 | 0.75 | 0.37 | 1.19 | 0.87 | 0.82 | 0.90 | 0.15 | 0.81 | 0.80 | ||
Pharmaceutical($M) | -0.00 | 0.22 | 0.07 | 0.86 | 0.09 | -0.00 | |||||||
1 metric has no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-03-25.
See a number that looks wrong?